- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Immunotherapy 2.0: Dr Patricia Salber Interviews Dr Harold Burstein
The field of immunotherapy is a work in progress and researchers are now expanding the use of this treatment and doing a better job of identifying the patients that will benefit the most from it.
During the latest Managed Care Cast, Patricia Salber, MD, MBA, of The Doctor Weighs In, interviews Harold J. Burstein, MD, PhD, an oncologist with the Dana-Farber Cancer Institute, about immunotherapy 2.0, which was named the advance of the year by the American Society of Clinical Oncology (ASCO). This is the second year in a row that ASCO named immunotherapy the advance of the year; however, immunotherapy 2.0 acknowledges the expanding use of immunotherapy.
According to Burstein, the report recognizes that immunotherapy is a work in progress and that researchers are now doing a better job of identifying patients and tumor subsets that will benefit the most from this therapy. During the interview, Burstein and Salber also discuss toxicities related to immunotherapy and paying for the treatment.
Listen below or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
